Amantadine

CHEBI:CHEBI_2618

Definition

A member of the class of adamantanes that is used as an antiviral and antiparkinson drug.

Chemical Information

Molecular Formula
C10H17N
Molecular Mass
151.24870
Charge
0
SMILES
NC12CC3CC(CC(C3)C1)C2
InChI
InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2
InChIKey
DKNWSYNQZKUICI-UHFFFAOYSA-N

Alternative Names

  • 1-adamantanamine
  • 1-adamantylamine
  • 1-aminoadamantane
  • adamantan-1-ylamine
  • amantadina
  • amantadine
  • Amantadine
  • amantadinum
  • Amantidine
  • Aminoadamantane
  • tricyclo[3.3.1.1(3,7)]decan-1-amine
  • tricyclo[3.3.1.1(3,7)]decan-1-ylamine
  • tricyclo[3.3.1.1(3,7)]decane-1-amine
  • Viregyt
  • Virosol

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:2618
DRON_00010000
620
oboInOwl#hasDbXref
Wikipedia:Amantadine

Additional References

Wikipedia:Amantadine

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

package_description
25 kg in 1 BOTTLE (10695-014-70)
package_ndc
70482-170-61
listing_expiration_date
20241231
route
ORAL
marketing_start_date
20201020
spl_id
f71aa8a6-9093-49ea-b9f2-23a69722dcd4
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
CAPSULE, COATED PELLETS
labeler_name
Spectrum Chemicals and Laboratory Products
application_number
ANDA070589
product_ndc
11014-0245
rxcui
2044726
manufacturer_name
APNAR PHARMA LP
package_marketing_start_date
19930628
unii
BF4C9Z1J53
core#notation
CHEBI:2618
active_ingredient_strength
129 mg/1
active_ingredient_name
AMANTADINE SULFATE
spl_set_id
5232b933-1df9-43b4-8ac2-61bfa4855e68
pharm_class_epc
Influenza A M2 Protein Inhibitor [EPC]
pharm_class
M2 Protein Inhibitors [MoA]
pharm_class_moa
M2 Protein Inhibitors [MoA]
nui
N0000175542
upc
0308321015001
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
620
generic_name
Amantadine Sulphate
brand_name
Amantadine HCl
brand_name_base
Amantadine HCl
oboInOwl#hasDbXref
Wikipedia:Amantadine
oboInOwl#id
CHEBI:2618
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_48560
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_parent_hydride
http://purl.obolibrary.org/obo/CHEBI_40519
chebi#is_conjugate_base_of
http://purl.obolibrary.org/obo/CHEBI_48320
has_treatment
http://purl.obolibrary.org/obo/DOID_8544
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_111364
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect11699
chebi#is_conjugate_acid_of
http://purl.obolibrary.org/obo/CHEBI_48320
owl#annotatedSource
t155537
owl#someValuesFrom
t3278172